Ventilatory support — indications
When to ventilate · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Type I (oxygenation) failure: PaO₂ <11 kPa on FiO₂ ≥0.4 — V/Q mismatch, shunt or diffusion limitation (pneumonia, pulmonary oedema, ARDS). Type II (ventilatory) failure: acute rise in PaCO₂ with significant respiratory acidosis — reduced minute ventilation (fatigue, weakness, sedation, airway obstruction) or increased dead space.
Red flags
- Respiratory rate persistently >35 or exhaustion — do not wait for the gas to prove failure
- Falling conscious level with rising CO₂
- A normal PaCO₂ in a severe asthmatic already signals failure
Assessment
Investigations
- Arterial blood gas (define type I vs II, trend the pH)
- CXR; bedside spirometry (VC in neuromuscular disease)
- Respiratory rate, pattern and accessory-muscle use over time
Management
- Treat the reversible cause first (bronchodilators, diuretics, antibiotics, naloxone as indicated)
- Trial of NIV/CPAP where appropriate (COPD with acidosis, cardiogenic pulmonary oedema, immunosuppressed)
- Intubate for: refractory hypoxaemia, progressive respiratory acidosis, exhaustion, airway compromise, or falling GCS
- In neuromuscular disease intubate on the TREND — VC falling towards 15 mL/kg — not on the gases, which fall late
- Set lung-protective ventilation from the outset (VT ~6 mL/kg predicted body weight)
Exam pearls
- The decision to ventilate is clinical — trends beat single numbers
- PaCO₂ is proportional to CO₂ production and inversely proportional to alveolar ventilation
Ventilate for the trajectory, not the snapshot.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.